Cargando…
Assessing vaccine-mediated protection in an ultra-low dose Mycobacterium tuberculosis murine model
Despite widespread immunization with Bacille-Calmette-Guerin (BCG), the only currently licensed tuberculosis (TB) vaccine, TB remains a leading cause of mortality globally. There are many TB vaccine candidates in the developmental pipeline, but the lack of a robust animal model to assess vaccine eff...
Autores principales: | Plumlee, C.R., Barrett, H.W., Shao, D.E., Lien, K.A., Cross, L.M., Cohen, S.B., Edlefsen, P.T, Urdahl, K.B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10055404/ https://www.ncbi.nlm.nih.gov/pubmed/36993415 http://dx.doi.org/10.1101/2023.03.22.533820 |
Ejemplares similares
-
Investigating Immune Correlates of Protection to Tuberculosis Using an Ultra-Low Dose Infection in a Mouse Model
por: Gern, Benjamin, et al.
Publicado: (2017) -
Attenuated Mycobacterium tuberculosis vaccine protection in a low-dose murine challenge model
por: Vidal, Samuel J., et al.
Publicado: (2023) -
Antibiotic Treatment during Gestation Enhances Susceptibility to Mycobacterium tuberculosis in Offspring
por: Nyangahu, Donald D., et al.
Publicado: (2022) -
Subunit vaccine H56/CAF01 induces a population of circulating CD4 T cells that traffic into the Mycobacterium tuberculosis-infected lung
por: Woodworth, Joshua S., et al.
Publicado: (2016) -
Contained Mycobacterium tuberculosis infection induces concomitant and heterologous protection
por: Nemeth, Johannes, et al.
Publicado: (2020)